RCM-Focused Introduction
Cardiology practices are facing one of the most aggressive reimbursement contractions in recent years. Over the past five years, Medicare payment cuts have resulted in a cumulative $700 million loss for cardiology services, and 2026 brings further reductions that will directly affect procedure-level revenue for practices performing pacemaker implants, ablations, percutaneous coronary interventions, and transcatheter aortic valve replacements. For specialty practices already managing rising operational costs and payer complexity, the revenue cycle implications are immediate and substantial.
1. Revenue Cycle Impact: Medicare Payment Reductions Erode Procedure-Level Revenue
Beginning in 2026, CMS will reduce the portion of hospital payments that covers indirect practice costs by 50%. The result is an estimated 10% cut to total payment values for high-volume cardiology procedures, including electrophysiology ablations, PCI, pacemaker implants, and TAVR. This reduction directly compresses per-case revenue for cardiology groups —whether they bill through hospital outpatient departments or ambulatory surgery centers. Revenue cycle teams must recalibrate expected reimbursement against updated fee schedules and monitor underpayments more closely than ever.
2. Revenue Cycle Impact: The -2.5% Efficiency Adjustment Adds Further Pressure
The 2026 Medicare Physician Fee Schedule includes a -2.5% efficiency adjustment that has drawn pushback from physician groups across specialties. For cardiology, this compounds the indirect practice cost reduction and accelerates the erosion of per-procedure margins. Revenue cycle operations should factor this into financial modeling, fee schedule updates, and payer contract benchmarking. Practices that fail to adjust projected collections risk overestimating cash flow and delaying corrective action.
3. Revenue Cycle Impact: Legislative Uncertainty Creates Planning Risk
Advocacy efforts are underway to reverse or delay these cuts. The American College of Cardiology is actively supporting the Strengthening Medicare for Patients and Providers Act (HR 6169), which would apply annual inflationary updates to the Physician Fee Schedule. Separately, the Efficiency Adjustment Delay Act (HR 7520) would postpone the -2.5% adjustment until 2030 and require CMS to provide empirical justification. While these legislative efforts may provide relief, the timeline remains uncertain. Revenue cycle teams should plan based on current rates while tracking legislative developments that could affect mid-year adjustments.
4. Revenue Cycle Impact: ASC Migration Brings New Coding and Payer Challenges
CMS added 573 new codes to the ASC Covered Procedures List for 2026, including several cardiovascular and electrophysiology ablation procedures. While this expansion creates opportunity, it also introduces revenue cycle complexity. Commercial payers have been slower to align coverage with Medicare’s ASC-eligible list, creating denial and pre-authorization delays for procedures that Medicare now covers in the outpatient setting. Cardiology practices migrating cases to ASCs need tighter coding workflows, payer-specific authorization tracking, and proactive denial prevention for newly eligible procedure codes.
5. Revenue Cycle Impact: Site Neutrality Legislation Could Reshape Reimbursement Models
Congress is expected to introduce site neutrality legislation that would further narrow the reimbursement gap between hospital outpatient departments and ASCs. For cardiology groups billing under HOPD rates, this could mean significant downward payment adjustments. For ASC-based practices, it may improve competitive positioning but will require updated contract negotiations with commercial payers. Revenue cycle leaders should model the financial impact of site-neutral payment scenarios and begin payer contract conversations now.
What This Means for Specialty Practices
Cardiology, along with orthopedics, pain management, and other procedural specialties, is entering a period where reimbursement is declining while operational costs continue to climb. Independent cardiology groups face a potential 5% to 15% revenue reduction without active intervention. Practices that depend on pacemaker implants, ablations, PCI, and TAVR need to prioritize underpayment recovery, coding accuracy, and denial prevention to protect every dollar of collectible revenue. The practices that treat revenue cycle management as a strategic function — not a back-office task — will be best positioned to sustain profitability through this period of payment instability.
How Cosentus Helps Cardiology Practices Protect Revenue
Cosentus partners with cardiology practices and ASCs to turn reimbursement pressure into a manageable challenge — not an existential one. With 25 years of specialty-focused RCM expertise and a team that combines real human judgment with AI-assisted analytics, Cosentus helps practices close the gap between what they earn and what they collect. Cosentus delivers measurable results for cardiology practices, including revenue and collections growth of up to 30%, through services that address the exact challenges this policy shift creates:
- Fee schedule monitoring and underpayment recovery to catch reimbursement shortfalls before they become write-offs
- Specialty-trained coding teams with expertise in cardiovascular procedure coding, modifier accuracy, and payer-specific documentation requirements
- Proactive denial prevention that identifies authorization gaps and documentation risks before claims are submitted — not after they’re denied
- Payer contract benchmarking to ensure reimbursement rates reflect current market conditions, not outdated agreements
- Real-time analytics and reporting that give practice leadership clear visibility into procedure-level profitability, payer performance, and collection trends
Revenue cycle management is no longer an afterthought. For cardiology practices navigating 2026, it is the difference between protecting margins and losing them.
